We4ClinicalResearch

23/07/2025

📢 𝗜𝘁'𝘀 𝗼𝗳𝗳𝗶𝗰𝗶𝗮𝗹: 𝗜𝗖𝗛 𝗚𝗖𝗣 𝗘𝟲(𝗥𝟯) 𝗶𝘀 𝗵𝗲𝗿𝗲.

The new Good Clinical Practice guideline is now live, and
it's not just a regulatory update. It redefines how we think about 𝗾𝘂𝗮𝗹𝗶𝘁𝘆, 𝗿𝗶𝘀𝗸, and 𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗳𝗹𝗲𝘅𝗶𝗯𝗶𝗹𝗶𝘁𝘆 in clinical research.

This shift affects everyone:
✅ Sponsors
✅ CROs
✅ Sites
✅ Clinical Operations
✅ QA & Compliance teams

But what's really changing?
And more importantly: 𝘄𝗵𝗮𝘁 𝘀𝗵𝗼𝘂𝗹𝗱 𝘆𝗼𝘂 𝗯𝗲 𝗱𝗼𝗶𝗻𝗴 𝗻𝗼𝘄?

To help you navigate the transition, we've launched a 𝟲-𝗽𝗮𝗿𝘁 𝘀𝗲𝗿𝗶𝗲𝘀 that breaks E6(R3) down into clear, actionable insights:

🔍 What's new
💡 How it impacts your day-to-day work
🎯 What concrete steps to take

Whether you're updating SOPs, planning PMCF studies, or
building decentralized trials, GCP R3 is the framework that brings structure and flexibility to your decisions.

📺 𝗠𝗶𝘀𝘀𝗲𝗱 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 𝟭? Catch up here → https://www.we4cr.com/gcp-r3-what-you-need-to-know/
📬 Follow us to get the next episodes as they drop

No buzzwords. No overcomplication.
Just a practical path to make GCP R3 work: for your team, your study, and your strategy.

21/07/2025

𝗚𝗖𝗣 𝗶𝘀 𝗲𝘃𝗼𝗹𝘃𝗶𝗻𝗴. 𝗔𝗿𝗲 𝘆𝗼𝘂? ✍

With the release of ICH E6(R3), clinical research enters a
new era, and this time 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗶𝘀 𝗳𝘂𝗹𝗹𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗴𝗮𝗺𝗲. There's
no need to worry, though: the first article in our GCPR3Explained is here to set the record straight!

Whether you're working on medical devices, SaMD, or digital
health solutions, the expectations around clinical evidence are shifting. From 𝗿𝗶𝘀𝗸-𝗯𝗮𝘀𝗲𝗱 𝘁𝗵𝗶𝗻𝗸𝗶𝗻𝗴 to 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗯𝘆 𝗗𝗲𝘀𝗶𝗴𝗻, the way we plan, run, and report clinical trials will never be the same.

In Episode 1 of our series, we break down:

✅ What's changing in the new GCP
✅ Why it matters for MedTech
✅ How to start adapting today

This is not just an update, it's a mindset shift.

👉 Read the article at https://www.we4cr.com/gcp-r3-what-you-need-to-know/ and join us as we deep dive into GCP R3, one principle at a time.

01/07/2025

🗓️ 𝗠𝗗𝗥 𝟮𝟬𝟮𝟱: 𝗻𝗲𝘄 𝗿𝘂𝗹𝗲𝘀, 𝗻𝗲𝘄 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀. 𝗔𝗿𝗲 𝘆𝗼𝘂 𝗿𝗲𝗮𝗱𝘆?

Got the 𝗲𝘅𝘁𝗲𝗻𝘀𝗶𝗼𝗻 for your 𝗹𝗲𝗴𝗮𝗰𝘆 𝗱𝗲𝘃𝗶𝗰𝗲? Great.

But now comes the second half of the movie: 𝗺𝗮𝗻𝗱𝗮𝘁𝗼𝗿𝘆 𝗶𝗺𝗽𝗹𝗮𝗻𝘁 𝗰𝗮𝗿𝗱𝘀, 𝗶𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗲𝗱 𝗔𝗜 𝗔𝗰𝘁, 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗣𝗠𝗖𝗙, and more complex 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗶𝗼𝗻𝘀.

In this new article, we explain:
✅ What's changing in 𝟮𝟬𝟮𝟱 for 𝗠𝗗𝘀 and 𝗦𝗮𝗠𝗗𝘀
✅ How to align 𝗠𝗗𝗥 and the 𝗔𝗜 𝗔𝗰𝘁 without wasting time (or your 𝗖𝗘 𝗺𝗮𝗿𝗸)
✅ Which 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘀𝘁𝘂𝗱𝗶𝗲𝘀 are worth launching now to avoid a 𝘀𝗰𝗿𝗮𝗺𝗯𝗹𝗲 𝗹𝗮𝘁𝗲𝗿

👉🏼 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗵𝗲𝗿𝗲:
🔗 https://rdar.li/9Blx0Oo

👩🏻💻 Questions about implant cards, CAPs, UDI or post-market surveillance?

𝗟𝗲𝘁'𝘀 𝘁𝗮𝗹𝗸.
👉🏼 https://rdar.li/el6lPMj

A single call can save you months (and costly rework).

27/06/2025

𝗖𝗘 𝗠𝗮𝗿𝗸 & 𝗠𝗗𝗥: 𝗔𝗿𝗲 𝗬𝗼𝘂 𝗥𝗲𝗮𝗹𝗹𝘆 𝗦𝗮𝗳𝗲 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲 𝗘𝘅𝘁𝗲𝗻𝘀𝗶𝗼𝗻?

In 2024, many manufacturers breathed a sigh of relief—the 𝗠𝗗𝗥 𝘁𝗿𝗮𝗻𝘀𝗶𝘁𝗶𝗼𝗻 𝗱𝗲𝗮𝗱𝗹𝗶𝗻𝗲𝘀 were extended.

But beware: not everyone 𝗾𝘂𝗮𝗹𝗶𝗳𝗶𝗲𝘀, and the 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝗺𝗲𝗻𝘁𝘀 are crystal clear.

⏳ An extension is not a freeze—it's a race full of hurdles.
In this article, we break down:

✅ The new 𝗱𝗲𝗮𝗱𝗹𝗶𝗻𝗲𝘀 𝗯𝘆 𝗿𝗶𝘀𝗸 𝗰𝗹𝗮𝘀𝘀
✅ ⁠The 𝗺𝗶𝗻𝗶𝗺𝘂𝗺 𝗰𝗿𝗶𝘁𝗲𝗿𝗶𝗮 to keep your 𝗖𝗘 𝗠𝗮𝗿𝗸
✅ What you need to do now 𝘁𝗼 𝘀𝘁𝗮𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗴𝗮𝗺𝗲

👉 Read our in-depth guide here:
🔗 https://www.we4cr.com/medical-devices-mdr-compliance/

🚀 Curious about what's changing in 2025? 𝗦𝘁𝗮𝘆 𝘁𝘂𝗻𝗲𝗱!

31/05/2025

🇮🇹
❤️ 𝗢𝗴𝗻𝗶 𝘀𝗶𝗴𝗮𝗿𝗲𝘁𝘁𝗮 𝘀𝗽𝗲𝗻𝘁𝗮 𝗲̀ 𝘂𝗻 𝗽𝗮𝘀𝘀𝗼 𝘃𝗲𝗿𝘀𝗼 𝘂𝗻 𝗰𝘂𝗼𝗿𝗲 𝗽𝗶𝘂̀ 𝘀𝗮𝗻𝗼.

Il fumo di tabacco è ancora oggi tra
le 𝗽𝗿𝗶𝗻𝗰𝗶𝗽𝗮𝗹𝗶 𝗰𝗮𝘂𝘀𝗲 𝗽𝗿𝗲𝘃𝗲𝗻𝗶𝗯𝗶𝗹𝗶 𝗱𝗶 𝗺𝗮𝗹𝗮𝘁𝘁𝗶𝗲 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝗼𝗹𝗮𝗿𝗶, responsabile del 𝟭𝟮% 𝗱𝗲𝗶 𝗱𝗲𝗰𝗲𝘀𝘀𝗶 𝗰𝗮𝗿𝗱𝗶𝗮𝗰𝗶 a livello globale.

Negli ultimi anni si è diffuso l'uso di si*****te elettroniche e dispositivi a riscaldamento del tabacco, spesso considerati "meno dannosi".

⚠️ 𝗠𝗲𝗻𝗼 𝗱𝗮𝗻𝗻𝗼𝘀𝗼 𝗻𝗼𝗻 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮 𝗶𝗻𝗻𝗼𝗰𝘂𝗼

Le 𝗲𝘃𝗶𝗱𝗲𝗻𝘇𝗲 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰𝗵𝗲 rivelano:
🔸 𝗽𝗿𝗲𝘀𝗲𝗻𝘇𝗮 𝗱𝗶 𝘀𝗼𝘀𝘁𝗮𝗻𝘇𝗲 𝘁𝗼𝘀𝘀𝗶𝗰𝗵𝗲
🔸 𝗶𝗻𝗳𝗶𝗮𝗺𝗺𝗮𝘇𝗶𝗼𝗻𝗶 𝗱𝗲𝗹𝗹𝗲 𝘃𝗶𝗲 𝗿𝗲𝘀𝗽𝗶𝗿𝗮𝘁𝗼𝗿𝗶𝗲
🔸 𝗽𝗼𝘁𝗲𝗻𝘇𝗶𝗮𝗹𝗶 𝗲𝗳𝗳𝗲𝘁𝘁𝗶 𝘀𝘂𝗹 𝘀𝗶𝘀𝘁𝗲𝗺𝗮 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝗼𝗹𝗮𝗿𝗲

📌 𝗟𝗮 𝗽𝗿𝗲𝘃𝗲𝗻𝘇𝗶𝗼𝗻𝗲 𝗻𝗮𝘀𝗰𝗲 𝗱𝗮𝗹𝗹𝗮 𝗰𝗼𝗻𝗼𝘀𝗰𝗲𝗻𝘇𝗮.

Una comunicazione chiara, basata su 𝗲𝘃𝗶𝗱𝗲𝗻𝘇𝗲 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰𝗵𝗲, è il primo passo per una 𝗽𝗿𝗲𝘃𝗲𝗻𝘇𝗶𝗼𝗻𝗲 𝗲𝗳𝗳𝗶𝗰𝗮𝗰𝗲.

In 𝗪𝗲𝟰 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 lavoriamo ogni giorno per migliorare la qualità della vita dei pazienti e rafforzare la 𝗽𝗿𝗲𝘃𝗲𝗻𝘇𝗶𝗼𝗻𝗲 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝗼𝗹𝗮𝗿𝗲:
✅ 𝗣𝗿𝗼𝗴𝗲𝘁𝘁𝗶 𝗲 𝘀𝘁𝘂𝗱𝗶 𝗰𝗹𝗶𝗻𝗶𝗰𝗶 mirati alla prevenzione e al trattamento delle patologie legate al fumo
✅ 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰𝗮 come leva per innovare la salute pubblica
✅ 𝗦𝘂𝗽𝗽𝗼𝗿𝘁𝗼 𝗮𝗱 𝗮𝘇𝗶𝗲𝗻𝗱𝗲 𝗲 𝗿𝗶𝗰𝗲𝗿𝗰𝗮𝘁𝗼𝗿𝗶 per sviluppare soluzioni di alta qualità

🔬💓 𝗟𝗮 𝗿𝗶𝗰𝗲𝗿𝗰𝗮 𝗰𝗹𝗶𝗻𝗶𝗰𝗮 𝗲̀ 𝗶𝗹 𝗰𝘂𝗼𝗿𝗲 𝗱𝗲𝗹𝗹𝗮 𝗽𝗿𝗲𝘃𝗲𝗻𝘇𝗶𝗼𝗻𝗲

🇬🇧
❤️ 𝗘𝘃𝗲𝗿𝘆 𝗰𝗶𝗴𝗮𝗿𝗲𝘁𝘁𝗲 𝗲𝘅𝘁𝗶𝗻𝗴𝘂𝗶𝘀𝗵𝗲𝗱 𝗶𝘀 𝗮 𝘀𝘁𝗲𝗽 𝘁𝗼𝘄𝗮𝗿𝗱𝘀 𝗮 𝗵𝗲𝗮𝗹𝘁𝗵𝗶𝗲𝗿 𝗵𝗲𝗮𝗿𝘁.

To***co smoking remains one of 𝘁𝗵𝗲 𝗺𝗮𝗶𝗻 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗮𝗯𝗹𝗲 𝗰𝗮𝘂𝘀𝗲𝘀 𝗼𝗳 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀, responsible for 𝟭𝟮% 𝗼𝗳 𝗰𝗮𝗿𝗱𝗶𝗮𝗰 𝗱𝗲𝗮𝘁𝗵𝘀 globally.

In recent years, the use of electronic ci******es and heat-not-burn to***co devices has spread, often considered "less harmful."

⚠️ 𝗟𝗲𝘀𝘀 𝗵𝗮𝗿𝗺𝗳𝘂𝗹 𝗱𝗼𝗲𝘀 𝗻𝗼𝘁 𝗺𝗲𝗮𝗻 𝗵𝗮𝗿𝗺𝗹𝗲𝘀𝘀

𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲 reveals:
🔸 𝘁𝗵𝗲 𝗽𝗿𝗲𝘀𝗲𝗻𝗰𝗲 𝗼𝗳 𝘁𝗼𝘅𝗶𝗰 𝘀𝘂𝗯𝘀𝘁𝗮𝗻𝗰𝗲𝘀
🔸 𝗶𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝗿𝗲𝘀𝗽𝗶𝗿𝗮𝘁𝗼𝗿𝘆 𝘁𝗿𝗮𝗰𝘁
🔸 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗲𝗳𝗳𝗲𝗰𝘁𝘀 𝗼𝗻 𝘁𝗵𝗲 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝘀𝘆𝘀𝘁𝗲𝗺

📌 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻 𝗯𝗲𝗴𝗶𝗻𝘀 𝘄𝗶𝘁𝗵 𝗸𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲.

Clear communication, based on 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲, is the first step towards 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻.

At 𝗪𝗲𝟰 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵, we work every day to improve the quality of life of patients and strengthen 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻:
✅ 𝗣𝗿𝗼𝗷𝗲𝗰𝘁𝘀 𝗮𝗻𝗱 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘀𝘁𝘂𝗱𝗶𝗲𝘀 focused on the prevention and treatment of smoking-related diseases
✅ 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 as a lever to innovate public health
✅ 𝗦𝘂𝗽𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗮𝗻𝗱 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀 to develop high-quality solutions

🔬💓 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗵𝗲𝗮𝗿𝘁 𝗼𝗳 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻.

***coDay

21/05/2025

🇮🇹
💡 𝗔𝗜 𝗻𝗲𝗹𝗹𝗮 𝗿𝗶𝗰𝗲𝗿𝗰𝗮 𝗰𝗹𝗶𝗻𝗶𝗰𝗮: 𝗿𝗶𝘃𝗼𝗹𝘂𝘇𝗶𝗼𝗻𝗲 𝗼 𝘀𝘂𝗽𝗽𝗼𝗿𝘁𝗼 𝗶𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝘁𝗲?

L'intelligenza artificiale sta trasformando la ricerca clinica:
📊 𝘀𝗲𝗹𝗲𝘇𝗶𝗼𝗻𝗲 𝗱𝗲𝗶 𝗽𝗮𝘇𝗶𝗲𝗻𝘁𝗶
🧠 𝘀𝗼𝗳𝘁𝘄𝗮𝗿𝗲 𝗽𝗿𝗲𝗱𝗶𝘁𝘁𝗶𝘃𝗶 (𝗦𝗮𝗠𝗗)
📡 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗮𝗴𝗴𝗶𝗼 𝗿𝗲𝗺𝗼𝘁𝗼
💻 𝘀𝘁𝘂𝗱𝗶 𝗱𝗲𝗰𝗲𝗻𝘁𝗿𝗮𝗹𝗶𝘇𝘇𝗮𝘁𝗶

Ma può davvero sostituire il CRA?
❌ 𝗡𝗼.

Il giudizio umano, l'etica, la relazione con i centri e la valutazione critica non si automatizzano.

In We4CR, l'AI è un alleato, non un sostituto:
✅ 𝗠𝗶𝗴𝗹𝗶𝗼𝗿𝗮 𝗰𝗶𝗼̀ 𝗰𝗵𝗲 𝗴𝗶𝗮̀ 𝗳𝗮𝗰𝗰𝗶𝗮𝗺𝗼
✅ 𝗦𝘂𝗽𝗽𝗼𝗿𝘁𝗮 𝗶𝗹 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗮𝗴𝗴𝗶𝗼 𝗱𝗲𝗹 𝗿𝗶𝘀𝗰𝗵𝗶𝗼
✅ 𝗔𝘂𝗺𝗲𝗻𝘁𝗮 𝗹'𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝘇𝗮

Ma il controllo resta sempre ai professionisti.
👩⚕️ 𝗜𝗹 𝗖𝗥𝗔 𝗲̀ 𝗶𝗹 𝗴𝗮𝗿𝗮𝗻𝘁𝗲 𝗱𝗲𝗹𝗹𝗮 𝗾𝘂𝗮𝗹𝗶𝘁𝗮̀
🤖 𝗟'𝗔𝗜 𝗲̀ 𝘂𝗻𝗼 𝘀𝘁𝗿𝘂𝗺𝗲𝗻𝘁𝗼 𝗽𝗼𝘁𝗲𝗻𝘁𝗲, 𝗺𝗮 𝘀𝗲𝗻𝘇𝗮 𝗮𝘂𝘁𝗼𝗻𝗼𝗺𝗶𝗮 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝗮𝗹𝗲

🔍 Leggi l'articolo completo sul nostro sito per approfondire:
✔️ 𝗶 𝘃𝗮𝗻𝘁𝗮𝗴𝗴𝗶 𝗿𝗲𝗮𝗹𝗶 𝗱𝗲𝗹𝗹'𝗔𝗜
✔️ 𝗶 𝗹𝗶𝗺𝗶𝘁𝗶 𝗻𝗼𝗿𝗺𝗮𝘁𝗶𝘃𝗶 𝗲𝗱 𝗲𝘁𝗶𝗰𝗶
✔️ 𝗹'𝗶𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘇𝗮 𝗱𝗲𝗹 𝗿𝘂𝗼𝗹𝗼 𝗱𝗲𝗹 𝗖𝗥𝗔
✔️ 𝗰𝗼𝗺𝗲 𝗴𝗲𝘀𝘁𝗶𝗿𝗲 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗽𝗲𝗿 𝗦𝗮𝗠𝗗 𝘀𝗲𝗰𝗼𝗻𝗱𝗼 𝗠𝗗𝗥 𝗲 𝗙𝗗𝗔

🔗 https://rdar.li/vo6DO9Q

𝗣𝗿𝗲𝗻𝗼𝘁𝗮 𝘂𝗻𝗮 𝗰𝗼𝗻𝘀𝘂𝗹𝗲𝗻𝘇𝗮 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝘇𝗮𝘁𝗮 𝗰𝗼𝗻 𝗻𝗼𝗶!
👉🏼 https://rdar.li/el6lPMj

🇬🇧
💡 𝗔𝗜 𝗶𝗻 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵: 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗼𝗿 𝗦𝗺𝗮𝗿𝘁 𝗦𝘂𝗽𝗽𝗼𝗿𝘁?

Artificial Intelligence is reshaping clinical research:
📊 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝘀𝗲𝗹𝗲𝗰𝘁𝗶𝗼𝗻
🧠 𝗽𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝘀𝗼𝗳𝘁𝘄𝗮𝗿𝗲 (𝗦𝗮𝗠𝗗)
📡 𝗿𝗲𝗺𝗼𝘁𝗲 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴
💻 𝗱𝗲𝗰𝗲𝗻𝘁𝗿𝗮𝗹𝗶𝘇𝗲𝗱 𝘁𝗿𝗶𝗮𝗹𝘀

But can it really replace the CRA?
❌ 𝗡𝗼.

Human judgment, ethics, site relationships, and critical thinking cannot be automated.

At We4CR, AI is an ally, not a replacement:
✅ 𝗜𝘁 𝗲𝗻𝗵𝗮𝗻𝗰𝗲𝘀 𝘄𝗵𝗮𝘁 𝘄𝗲 𝗮𝗹𝗿𝗲𝗮𝗱𝘆 𝗱𝗼
✅ 𝗦𝘂𝗽𝗽𝗼𝗿𝘁𝘀 𝗿𝗶𝘀𝗸-𝗯𝗮𝘀𝗲𝗱 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴
✅ 𝗕𝗼𝗼𝘀𝘁𝘀 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆

But control always remains in the hands of professionals.
👩⚕️ 𝗧𝗵𝗲 𝗖𝗥𝗔 𝗶𝘀 𝘁𝗵𝗲 𝗴𝘂𝗮𝗿𝗱𝗶𝗮𝗻 𝗼𝗳 𝗾𝘂𝗮𝗹𝗶𝘁𝘆
🤖 𝗔𝗜 𝗶𝘀 𝗮 𝗽𝗼𝘄𝗲𝗿𝗳𝘂𝗹 𝘁𝗼𝗼𝗹, 𝗯𝘂𝘁 𝗶𝘁 𝗹𝗮𝗰𝗸𝘀 𝗶𝗻𝗱𝗲𝗽𝗲𝗻𝗱𝗲𝗻𝘁 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻-𝗺𝗮𝗸𝗶𝗻𝗴

🔍 Read the full article on our website to explore:
✔️ t𝗵𝗲 𝗿𝗲𝗮𝗹 𝗯𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗼𝗳 𝗔𝗜
✔️ 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗮𝗻𝗱 𝗲𝘁𝗵𝗶𝗰𝗮𝗹 𝗹𝗶𝗺𝗶𝘁𝗮𝘁𝗶𝗼𝗻𝘀
✔️ 𝘁𝗵𝗲 𝗶𝗿𝗿𝗲𝗽𝗹𝗮𝗰𝗲𝗮𝗯𝗹𝗲 𝘃𝗮𝗹𝘂𝗲 𝗼𝗳 𝗖𝗥𝗔𝘀
✔️ 𝗵𝗼𝘄 𝘁𝗼 𝗺𝗮𝗻𝗮𝗴𝗲 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗳𝗼𝗿 𝗦𝗮𝗠𝗗 𝘂𝗻𝗱𝗲𝗿 𝗠𝗗𝗥 𝗮𝗻𝗱 𝗙𝗗𝗔 𝗴𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲𝘀

🔗 https://rdar.li/vo6DO9Q

𝗕𝗼𝗼𝗸 𝗮 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗰𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝘂𝘀!
👉🏼 https://rdar.li/el6lPMj

03/04/2025

🇮🇹
Meno burocrazia, più 𝗿𝗶𝗰𝗲𝗿𝗰𝗮 𝗰𝗹𝗶𝗻𝗶𝗰𝗮 in Italia 🚀

La riforma dei 𝗖𝗼𝗺𝗶𝘁𝗮𝘁𝗶 𝗘𝘁𝗶𝗰𝗶 (𝗖𝗘) ha finalmente reso il processo di approvazione più veloce e prevedibile, grazie a:

🔹 𝗥𝗶𝗱𝘂𝘇𝗶𝗼𝗻𝗲 𝗱𝗲𝗹 𝗻𝘂𝗺𝗲𝗿𝗼 𝗱𝗶 𝗖𝗘 → Da oltre 90 a 40 CET specializzati;
🔹 𝗣𝗿𝗼𝗰𝗲𝗱𝘂𝗿𝗲 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱𝗶𝘇𝘇𝗮𝘁𝗲 → Valutazioni uniformi e tempi certi;
🔹 𝗔𝗹𝗹𝗶𝗻𝗲𝗮𝗺𝗲𝗻𝘁𝗼 𝗲𝘂𝗿𝗼𝗽𝗲𝗼 → Conformità al Regolamento MDR 2017/745.

📌 Cosa cambia per la ricerca clinica?

✅ 𝗦𝘁𝘂𝗱𝗶 𝗮𝘃𝘃𝗶𝗮𝘁𝗶 𝗶𝗻 𝘁𝗲𝗺𝗽𝗶 𝗿𝗲𝗰𝗼𝗿𝗱
✅ 𝗠𝗲𝗻𝗼 𝗼𝘀𝘁𝗮𝗰𝗼𝗹𝗶 𝗯𝘂𝗿𝗼𝗰𝗿𝗮𝘁𝗶𝗰𝗶 𝗽𝗲𝗿 𝗿𝗶𝗰𝗲𝗿𝗰𝗮𝘁𝗼𝗿𝗶 𝗲 𝘀𝗽𝗼𝗻𝘀𝗼𝗿
✅ 𝗜𝘁𝗮𝗹𝗶𝗮 𝗽𝗶𝘂̀ 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗮 𝗮 𝗹𝗶𝘃𝗲𝗹𝗹𝗼 𝗶𝗻𝘁𝗲𝗿𝗻𝗮𝘇𝗶𝗼𝗻𝗮𝗹𝗲

💡 We4 Clinical Research ti supporta con:

👉 𝗚𝗲𝘀𝘁𝗶𝗼𝗻𝗲 𝘀𝗼𝘁𝘁𝗼𝗺𝗶𝘀𝘀𝗶𝗼𝗻𝗶 𝗲 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲
👉 𝗖𝗼𝗺𝘂𝗻𝗶𝗰𝗮𝘇𝗶𝗼𝗻𝗲 𝗲𝗳𝗳𝗶𝗰𝗮𝗰𝗲 con i nuovi CET
👉 𝗖𝗼𝗻𝘀𝘂𝗹𝗲𝗻𝘇𝗮 𝘀𝘂 𝗺𝗶𝘀𝘂𝗿𝗮 per adattarti alla normativa

Cerchi una soluzione senza stress?

𝗥𝗶𝗰𝗵𝗶𝗲𝗱𝗶 𝘂𝗻𝗮 𝗰𝗼𝗻𝘀𝘂𝗹𝗲𝗻𝘇𝗮 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝘇𝗮𝘁𝗮
👉 https://lnkd.in/dFwj6xJG

🇬🇧
Less bureaucracy, more 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 in Italy 🚀

The reform of 𝗘𝘁𝗵𝗶𝗰𝗮𝗹 𝗖𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗲𝘀 (𝗘𝗖) has finally made the approval process faster and more predictable, thanks to:

🔹 𝗥𝗲𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗶𝗻 𝘁𝗵𝗲 𝗻𝘂𝗺𝗯𝗲𝗿 𝗼𝗳 𝗘𝗖𝘀 → From over 90 to 40 specialized Ethical Committees (CET);
🔹 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱𝗶𝘇𝗲𝗱 𝗽𝗿𝗼𝗰𝗲𝗱𝘂𝗿𝗲𝘀 → Uniform evaluations and fixed timelines;
🔹 𝗘𝗨 𝗮𝗹𝗶𝗴𝗻𝗺𝗲𝗻𝘁 → Compliance with the EU MDR 2017/745 Regulation.

📌 What changes for clinical research?

✅ 𝗦𝘁𝘂𝗱𝗶𝗲𝘀 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝗱 𝗶𝗻 𝗿𝗲𝗰𝗼𝗿𝗱 𝘁𝗶𝗺𝗲
✅ 𝗙𝗲𝘄𝗲𝗿 𝗯𝘂𝗿𝗲𝗮𝘂𝗰𝗿𝗮𝘁𝗶𝗰 𝗵𝘂𝗿𝗱𝗹𝗲𝘀 𝗳𝗼𝗿 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀 𝗮𝗻𝗱 𝘀𝗽𝗼𝗻𝘀𝗼𝗿𝘀
✅ 𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗲𝗱 𝗶𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲𝗻𝗲𝘀𝘀 𝗳𝗼𝗿 𝗜𝘁𝗮𝗹𝘆

💡 We4 Clinical Research supports you with:

👉 𝗦𝘁𝗿𝗲𝗮𝗺𝗹𝗶𝗻𝗲𝗱 𝘀𝘂𝗯𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝗮𝗻𝗱 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁
👉 𝗘𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 𝗰𝗼𝗺𝗺𝘂𝗻𝗶𝗰𝗮𝘁𝗶𝗼𝗻 with new CETs
👉 𝗧𝗮𝗶𝗹𝗼𝗿𝗲𝗱 𝗰𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝗻𝗰𝘆 to adapt to the new regulations

Looking for a stress-free solution?

𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗮 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗰𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝘁𝗶𝗼𝗻
👉 https://lnkd.in/dFwj6xJG

08/03/2025

🇮🇹
✨ 𝗟𝗮 𝗽𝗮𝗿𝗶𝘁𝗮̀ 𝗱𝗶 𝗴𝗲𝗻𝗲𝗿𝗲 𝗻𝗼𝗻 𝗲̀ 𝘀𝗼𝗹𝗼 𝘂𝗻 𝘃𝗮𝗹𝗼𝗿𝗲, 𝗺𝗮 𝘂𝗻 𝗶𝗺𝗽𝗲𝗴𝗻𝗼 𝗰𝗼𝗻𝗰𝗿𝗲𝘁𝗼. ✨

In occasione della 𝗚𝗶𝗼𝗿𝗻𝗮𝘁𝗮 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘇𝗶𝗼𝗻𝗮𝗹𝗲 𝗱𝗲𝗹𝗹𝗮 𝗗𝗼𝗻𝗻𝗮, ribadiamo il nostro impegno nel creare ambienti di lavoro equi e inclusivi.

In We4 Clinical Research crediamo che tali ambienti siano fondamentali per la crescita delle persone e il successo dell'azienda.

Per questo adottiamo politiche che garantiscono:

✅ 𝗣𝗮𝗿𝗶 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗮̀ per la crescita professionale
✅ 𝗘𝗾𝘂𝗶𝘁𝗮̀ 𝘀𝗮𝗹𝗮𝗿𝗶𝗮𝗹𝗲 attraverso trasparenza e meritocrazia
✅ 𝗙𝗹𝗲𝘀𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝗮̀ 𝗹𝗮𝘃𝗼𝗿𝗮𝘁𝗶𝘃𝗮 per un migliore equilibrio vita-lavoro
✅ 𝗦𝘂𝗽𝗽𝗼𝗿𝘁𝗼 𝗮𝗹𝗹𝗮 𝗴𝗲𝗻𝗶𝘁𝗼𝗿𝗶𝗮𝗹𝗶𝘁𝗮̀ per valorizzare il contributo di tutti

Siamo orgogliosi di annunciare che stiamo per ottenere la 𝗰𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘇𝗶𝗼𝗻𝗲 𝘀𝘂𝗹𝗹𝗮 𝗽𝗮𝗿𝗶𝘁𝗮̀ 𝗱𝗶 𝗴𝗲𝗻𝗲𝗿𝗲, un riconoscimento che attesta il nostro impegno nel creare un luogo di lavoro dove ogni talento può esprimersi senza barriere.

🔗 Leggi il nostro articolo per scoprire come rendiamo la parità di genere una realtà concreta ogni giorno.

👉🏼 https://www.we4cr.com/we4-clinical-research-gender-equality-certification/

📢 E tu, quali iniziative ritieni fondamentali per promuovere l'inclusione sul lavoro?

Condividi la tua esperienza nei commenti!

🇬🇧
✨ 𝗚𝗲𝗻𝗱𝗲𝗿 𝗲𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗶𝘀 𝗻𝗼𝘁 𝗷𝘂𝘀𝘁 𝗮 𝘃𝗮𝗹𝘂𝗲, 𝗯𝘂𝘁 𝗮 𝗰𝗼𝗻𝗰𝗿𝗲𝘁𝗲 𝗰𝗼𝗺𝗺𝗶𝘁𝗺𝗲𝗻𝘁. ✨

On 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗪𝗼𝗺𝗲𝗻'𝘀 𝗗𝗮𝘆, we reaffirm our commitment to creating fair and inclusive work environments. At We4 Clinical Research, we believe that such environments are essential for both personal growth and the overall success of our company.

To achieve this, we have implemented policies that ensure:

✅ 𝗘𝗾𝘂𝗮𝗹 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 for professional advancement
✅ 𝗣𝗮𝘆 𝗲𝗾𝘂𝗶𝘁𝘆 through transparency and meritocracy
✅ 𝗙𝗹𝗲𝘅𝗶𝗯𝗹𝗲 𝘄𝗼𝗿𝗸𝗶𝗻𝗴 arrangements for a better work-life balance
✅ 𝗣𝗮𝗿𝗲𝗻𝘁𝗮𝗹 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 to recognize and value everyone's contribution

We are proud to announce that we are on track to acquire the 𝗚𝗲𝗻𝗱𝗲𝗿 𝗘𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗖𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻—a recognition that affirms our commitment to fostering a workplace where every talent can shine without barriers.

🔗 Read our article to discover how we make gender equality a tangible reality every day.

👉🏼 https://www.we4cr.com/we4-clinical-research-gender-equality-certification/

📢 What initiatives do you believe are essential for promoting inclusion in the workplace?

Share your thoughts in the comments!

Esplora il nostro impegno nel creare un ambiente di lavoro equo, inclusivo e orientato all’eccellenza.

05/07/2022

A clinical study involves research using human (also called participants) that is intended to add to medical knowledge.
There are two main types of clinical studies:
⚫ (also called interventional studies)
⚫ observational studies

We4CR conducts both interventional and observational studies.

Learn more about clinical trial 👉 https://www.we4cr.com/clinical-trial/

27/06/2022

Every trial must be recorded in a publically accessible database before the study starts, or within 30 days from its start. Clinicaltrial.gov is the most common site. A registered user can submit the study on the database, following the instruction provided in the webpage. At the end of the process, the study will be assigned a unique code that can be used in all official documentation as a reference number for the study (when applicable). Any records must be kept up to date.

👉 https://www.we4cr.com/set-up/

26/06/2022

What is Clinicaltrial.gov?

👉 https://www.we4cr.com/clinicaltrials-gov/

24/06/2022

Before the start of the study, one or more meetings may be scheduled.
A kick-off meeting is the first meeting between the project team and the project stakeholder, who can either be internal or external. The meeting is an opportunity to sync up and discuss everything that will guide the project to success.
👉 https://www.we4cr.com/set-up/